ARTEMIS MEDICARE is selling at 412.80 as of the 23rd of October 2021; that is 3.48 percent up since the beginning of the trading day. The stock's lowest day price was 394.0. Equity ratings for ARTEMIS MEDICARE are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of October 2020 and ending today, the 23rd of October 2021. Click here to learn more.
Check how we calculate scores


Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. ARTEMIS MEDICARE's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding ARTEMIS MEDICARE or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
ARTEMIS MEDICARE is not yet fully synchronised with the market data
ARTEMIS MEDICARE is way too risky over 90 days horizon
ARTEMIS MEDICARE appears to be risky and price may revert if volatility continues
The company has accumulated 1.47 B in total debt with debt to equity ratio (D/E) of 0.46, which is about average as compared to similar companies. ARTEMIS MEDICARE has a current ratio of 0.9, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due.
About 81.0% of ARTEMIS MEDICARE shares are held by company insiders
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of ARTEMIS MEDICARE's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedOvervalued
ARTEMIS MEDICARE (ARTEMISMED) is traded on National Stock Exchange of India in India and employs 1,517 people. ARTEMIS MEDICARE has accumulated about 311.2 M in cash with 272.61 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.35.
Check ARTEMIS MEDICARE Probability Of Bankruptcy

ARTEMIS Stock Price Odds Analysis

What are ARTEMIS MEDICARE's target price odds to finish over the current price? In regard to a normal probability distribution, the odds of ARTEMIS MEDICARE jumping above the current price in 90 days from now is roughly 2.32%. The ARTEMIS MEDICARE probability density function shows the probability of ARTEMIS MEDICARE stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon ARTEMIS MEDICARE has a beta of -0.9221. This suggests Moreover, the company has an alpha of 1.5445, implying that it can generate a 1.54 percent excess return over DOW after adjusting for the inherited market risk (beta).
 Odds Down 412.8HorizonTargetOdds Up 412.8 
97.66%90 days
Based on a normal probability distribution, the odds of ARTEMIS MEDICARE to move above the current price in 90 days from now is roughly 2.32 (This ARTEMIS MEDICARE probability density function shows the probability of ARTEMIS Stock to fall within a particular range of prices over 90 days) .


Investors will always prefer to have the highest possible return on investment while minimizing volatility. ARTEMIS MEDICARE market risk premium is the additional return an investor will receive from holding ARTEMIS MEDICARE long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in ARTEMIS MEDICARE. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although ARTEMIS MEDICARE's alpha and beta are two of the key measurements used to evaluate ARTEMIS MEDICARE's performance over the market, the standard measures of volatility play an important role as well.

ARTEMIS Stock Against Markets

Picking the right benchmark for ARTEMIS MEDICARE stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in ARTEMIS MEDICARE stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for ARTEMIS MEDICARE is critical whether you are bullish or bearish towards ARTEMIS MEDICARE at a given time.

View Currently Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ARTEMIS MEDICARE stock to make a market-neutral strategy. Peer analysis of ARTEMIS MEDICARE could also be used in its relative valuation, which is a method of valuing ARTEMIS MEDICARE by comparing valuation metrics with similar companies.
Please continue to Trending Equities. Note that the ARTEMIS MEDICARE information on this page should be used as a complementary analysis to other ARTEMIS MEDICARE's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Tools for ARTEMIS Stock

When running ARTEMIS MEDICARE price analysis, check to measure ARTEMIS MEDICARE's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ARTEMIS MEDICARE is operating at the current time. Most of ARTEMIS MEDICARE's value examination focuses on studying past and present price action to predict the probability of ARTEMIS MEDICARE's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move ARTEMIS MEDICARE's price. Additionally, you may evaluate how the addition of ARTEMIS MEDICARE to your portfolios can decrease your overall portfolio volatility.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope